A detailed history of Louisiana State Employees Retirement System transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 15,600 shares of COLL stock, worth $508,404. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,600
Previous 16,500 5.45%
Holding current value
$508,404
Previous $531,000 13.37%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$31.4 - $39.07 $28,260 - $35,163
-900 Reduced 5.45%
15,600 $602,000
Q2 2024

Jul 24, 2024

BUY
$31.36 - $39.99 $9,408 - $11,997
300 Added 1.85%
16,500 $531,000
Q1 2024

Apr 23, 2024

SELL
$31.23 - $40.91 $3,123 - $4,090
-100 Reduced 0.61%
16,200 $628,000
Q4 2023

Jan 29, 2024

SELL
$21.16 - $30.8 $29,624 - $43,120
-1,400 Reduced 7.91%
16,300 $501,000
Q3 2023

Oct 17, 2023

SELL
$21.23 - $24.28 $10,615 - $12,140
-500 Reduced 2.75%
17,700 $395,000
Q2 2023

Jul 18, 2023

BUY
$21.06 - $24.0 $54,756 - $62,400
2,600 Added 16.67%
18,200 $391,000
Q1 2023

Apr 19, 2023

SELL
$23.0 - $29.88 $6,900 - $8,964
-300 Reduced 1.89%
15,600 $374,000
Q4 2022

Jan 24, 2023

SELL
$16.14 - $23.55 $6,456 - $9,420
-400 Reduced 2.45%
15,900 $369,000
Q3 2022

Oct 19, 2022

SELL
$15.46 - $20.1 $1,546 - $2,010
-100 Reduced 0.61%
16,300 $261,000
Q2 2022

Jul 20, 2022

SELL
$14.22 - $20.88 $5,688 - $8,352
-400 Reduced 2.38%
16,400 $277,000
Q1 2022

Apr 22, 2022

BUY
$17.2 - $22.5 $1,720 - $2,250
100 Added 0.6%
16,800 $303,000
Q4 2021

Jan 14, 2022

SELL
$17.5 - $21.35 $7,000 - $8,540
-400 Reduced 2.34%
16,700 $312,000
Q3 2021

Oct 12, 2021

BUY
$17.75 - $25.39 $21,300 - $30,468
1,200 Added 7.55%
17,100 $338,000
Q2 2021

Jul 16, 2021

BUY
$21.74 - $25.28 $2,174 - $2,528
100 Added 0.63%
15,900 $376,000
Q1 2021

Apr 14, 2021

BUY
$19.25 - $26.1 $304,150 - $412,380
15,800 New
15,800 $374,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.